188 related articles for article (PubMed ID: 24788754)
1. PTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling.
Ono H; Basson MD; Ito H
PLoS One; 2014; 9(5):e96060. PubMed ID: 24788754
[TBL] [Abstract][Full Text] [Related]
2. PTK6 Potentiates Gemcitabine-Induced Apoptosis by Prolonging S-phase and Enhancing DNA Damage in Pancreatic Cancer.
Ono H; Basson MD; Ito H
Mol Cancer Res; 2015 Aug; 13(8):1174-84. PubMed ID: 26013168
[TBL] [Abstract][Full Text] [Related]
3. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
[TBL] [Abstract][Full Text] [Related]
4. Protein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrate.
Zheng Y; Asara JM; Tyner AL
J Biol Chem; 2012 Jan; 287(1):148-158. PubMed ID: 22084245
[TBL] [Abstract][Full Text] [Related]
5. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
6. Interference of PTK6/GAB1 signaling inhibits cell proliferation, invasion, and migration of cervical cancer cells.
Li J; Yang N; Tian X; Ouyang L; Jiang M; Zhang S
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35894144
[TBL] [Abstract][Full Text] [Related]
7. Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.
Mathur PS; Gierut JJ; Guzman G; Xie H; Xicola RM; Llor X; Chastkofsky MI; Perekatt AO; Tyner AL
Mol Cancer Res; 2016 Jun; 14(6):563-73. PubMed ID: 26983689
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate induces the migration of thyroid follicular carcinoma cells through the microRNA-17/PTK6/ERK1/2 pathway.
Zhao S; Li J
PLoS One; 2015; 10(3):e0119148. PubMed ID: 25748447
[TBL] [Abstract][Full Text] [Related]
9. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract][Full Text] [Related]
11. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
12. Insulin promotes invasion and migration of KRAS
Wang G; Yin L; Peng Y; Gao Y; Gao H; Zhang J; Lv N; Miao Y; Lu Z
Cell Prolif; 2019 May; 52(3):e12575. PubMed ID: 30838710
[TBL] [Abstract][Full Text] [Related]
13. PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways.
Feng J; Ma T; Ge Z; Lin J; Ding W; Chen H; Zhu W; Zhou S; Tan Y
Mol Med Rep; 2015 Mar; 11(3):2111-7. PubMed ID: 25411978
[TBL] [Abstract][Full Text] [Related]
14. KiSS‑1‑mediated suppression of the invasive ability of human pancreatic carcinoma cells is not dependent on the level of KiSS‑1 receptor GPR54.
Wang CH; Qiao C; Wang RC; Zhou WP
Mol Med Rep; 2016 Jan; 13(1):123-9. PubMed ID: 26572251
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor.
Zheng Y; Peng M; Wang Z; Asara JM; Tyner AL
Mol Cell Biol; 2010 Sep; 30(17):4280-92. PubMed ID: 20606012
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
Qiu L; Levine K; Gajiwala KS; Cronin CN; Nagata A; Johnson E; Kraus M; Tatlock J; Kania R; Foley T; Sun S
PLoS One; 2018; 13(6):e0198374. PubMed ID: 29879184
[TBL] [Abstract][Full Text] [Related]
18. HIF-1α-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion.
Pires IM; Blokland NJ; Broos AW; Poujade FA; Senra JM; Eccles SA; Span PN; Harvey AJ; Hammond EM
Cancer Biol Ther; 2014 Oct; 15(10):1350-7. PubMed ID: 25019382
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of protein tyrosine kinase 6 contributes to tumor progression and metastasis in laryngeal squamous cell carcinoma.
Wu D; Zhang X; Liu Z; Yan H; Mai J; Zhao Z; Zhong Q; Liu X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1378-1384. PubMed ID: 30029880
[TBL] [Abstract][Full Text] [Related]
20. PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and MigratiOn Through Phosphorylation of Eps8.
Shin WS; Shim HJ; Lee YH; Pyo M; Park JS; Ahn SY; Lee ST
J Cell Biochem; 2017 Sep; 118(9):2887-2895. PubMed ID: 28214294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
